<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36920">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02032121</url>
  </required_header>
  <id_info>
    <org_study_id>20070584</org_study_id>
    <nct_id>NCT02032121</nct_id>
  </id_info>
  <brief_title>Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors</brief_title>
  <official_title>Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Survivors of childhood cancer have an increased risk of death from cardiovascular disease
      due to both the therapies they received while undergoing treatment and diet and lifestyle
      factors. The nature of cardiovascular risk and the interaction between treatment affects and
      cardiovascular risk factors is unknown. We propose to study vascular inflammatory markers as
      well as measure of blood vessel stiffness (both of which are predictive of early heart
      disease) in 100 pediatric cancer survivors and 100 control children. Characterization of
      vascular inflammation and stiffness in long-term survivors will allow for the development of
      future interventions to decrease inflammation through both pharmacologic and lifestyle
      modifications.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Vascular Inflammation</measure>
    <time_frame>single time point at initial visit</time_frame>
    <safety_issue>No</safety_issue>
    <description>All study procedures to assess vascular inflammation will be assessed through specimen sample collection and through procedures such as (echocardiograph)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cancer Survivor</condition>
  <arm_group>
    <arm_group_label>Intervention procedures</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All the procedures will be completed for every subject</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood specimen</intervention_name>
    <arm_group_label>Intervention procedures</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Echocardiography</intervention_name>
    <arm_group_label>Intervention procedures</arm_group_label>
    <other_name>Flow mediated vasodilation</other_name>
    <other_name>Carotid intimal media thickness</other_name>
    <other_name>Bone Mineral Density</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  6-30 years of age

          -  2 years from the completion of therapy for cancer

          -  free of active disease

        Exclusion Criteria:

          -  &lt;6 or &gt; 30 years of age

          -  current cancer treatment or inside of 2 years post treatment

          -  Active disease/infection
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tracie L Miller, MD, SM</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gabriel Somarriba, DPT</last_name>
    <phone>305-243-4304</phone>
    <email>GSomarriba2@med.miami.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Miami, MIller School of Medicine</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriel Somarriba, DPT</last_name>
      <phone>305-243-4304</phone>
      <email>GSomarriba2@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Tracie L Miller, MD, SM</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina Fernandes, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 8, 2014</lastchanged_date>
  <firstreceived_date>January 8, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Tracie L. Miller, MD</investigator_full_name>
    <investigator_title>Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Cancer survivors</keyword>
  <keyword>Long-term cancer survivor</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
